ICAM1 and vitiligo: Hwang et al. (1999) reported that the serum level of soluble intercellular adhesion molecule-1 was significantly decreased after systemic steroid treatment in the clinically improved group. El-Domyati et al. (2021) revealed that the levels of C-X-C motif chemokine ligand (CXCL) 10 were decreased in the serum and lesions of vitiligo patients after systemic steroid treatments.